Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, February 24, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
admin
-
February 3, 2025
Latest Pharma-News
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
admin
-
February 3, 2025
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
EVENITY® (romosozumab) approved by European Commission (EC) for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture
admin
-
December 13, 2019
0
Latest Pharma-News
U.S. FDA OKs for Pfizer’s XELJANZ® XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis
admin
-
December 13, 2019
0
Latest Pharma-News
The U.S. Food and Drug Administration granted accelerated approval for the first targeted treatment, Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy
admin
-
December 13, 2019
0
Latest Pharma-News
Innovative diabetes management solution (Accu-Chek SugarView app) announced by Roche
admin
-
December 11, 2019
0
Latest Pharma-News
Daiichi Sankyo Initiates Pivotal Phase 2 Trial in Japan with Valemetostat to treat patients with adult T-cell leukemia-lymphoma
admin
-
December 11, 2019
0
Latest Pharma-News
Healx collaborates with Boehringer Ingelheim to discover new treatment approaches for rare neurological diseases
admin
-
December 11, 2019
0
Latest Pharma-News
GenesisCare launched UK’s first MRIdian radiotherapy machine: a new radiotherapy treatment to reduce treatment time
admin
-
December 11, 2019
0
Latest Pharma-News
FDA OKs to Navigen for its IND Application to Initiate First-in-Human Studies for CPT31, a Novel, D-peptide HIV Entry Inhibitor
admin
-
December 11, 2019
0
Latest Pharma-News
Sesen Bio Initiates Rolling Submission of BLA for Vicinium to FDA for the treatment of BCG-unresponsive non-muscle invasive bladder cancer
admin
-
December 11, 2019
0
Latest Pharma-News
First and only ingestible event marker (the ID-Cap® System)approved by U.S. FDA
admin
-
December 11, 2019
0
Latest Pharma-News
Moberg Pharma meets primary endpoint for MOB-015 (topical terbinafine) in a phase 3 study for the treatment of Onychomycosis
admin
-
December 10, 2019
0
Latest Pharma-News
U.S. FDA approved Fast Track designation for Equillium’s itolizumab (EQUALISE Phase 1b study )for the treatment of lupus nephritis
admin
-
December 10, 2019
0
1
...
137
138
139
...
145
Page 138 of 145
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025